HSP90AA1 and ovarian carcinoma: As a new target for cancer therapy, HSP90AA1 is highly expressed in a variety of malignant tumors, including breast cancer, endometrial cancer, ovarian cancer, colon cancer, lung cancer and prostate cancer [29].